HEADER TRANSFERASE/TRANSFERASE INHIBITOR 22-SEP-15 5DWR TITLE IDENTIFICATION OF N-(4-((1R,3S,5S)-3-AMINO-5-METHYLCYCLOHEXYL)PYRIDIN- TITLE 2 3-YL)-6-(2,6-DIFLUOROPHENYL)-5-FLUOROPICOLINAMIDE (PIM447), A POTENT TITLE 3 AND SELECTIVE PROVIRAL INSERTION SITE OF MOLONEY MURINE LEUKEMIA TITLE 4 (PIM) 1,2 AND 3 KINASE INHIBITOR IN CLINICAL TRIALS FOR HEMATOLOGICAL TITLE 5 MALIGNANCIES COMPND MOL_ID: 1; COMPND 2 MOLECULE: SERINE/THREONINE-PROTEIN KINASE PIM-1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 93-404; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PIM1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PIM1, MOLONEY MURINE LEUKEMIA, PIM447, KINASE INHIBITOR, TRANSFERASE- KEYWDS 2 TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.BELLAMACINA,D.BUSSIERE,M.BURGER REVDAT 2 25-NOV-15 5DWR 1 JRNL REVDAT 1 11-NOV-15 5DWR 0 JRNL AUTH M.T.BURGER,G.NISHIGUCHI,W.HAN,J.LAN,R.SIMMONS,G.ATALLAH, JRNL AUTH 2 Y.DING,V.TAMEZ,Y.ZHANG,M.MATHUR,K.MULLER,C.BELLAMACINA, JRNL AUTH 3 M.K.LINDVALL,R.ZANG,K.HUH,P.FEUCHT,T.ZAVOROTINSKAYA,Y.DAI, JRNL AUTH 4 S.BASHAM,J.CHAN,E.GINN,A.AYCINENA,J.HOLASH,J.CASTILLO, JRNL AUTH 5 J.L.LANGOWSKI,Y.WANG,M.Y.CHEN,A.LAMBERT,C.FRITSCH, JRNL AUTH 6 A.KAUFFMANN,E.PFISTER,K.G.VANASSE,P.D.GARCIA JRNL TITL IDENTIFICATION OF JRNL TITL 2 N-(4-((1R,3S,5S)-3-AMINO-5-METHYLCYCLOHEXYL)PYRIDIN-3-YL) JRNL TITL 3 -6-(2,6-DIFLUOROPHENYL)-5-FLUOROPICOLINAMIDE (PIM447), A JRNL TITL 4 POTENT AND SELECTIVE PROVIRAL INSERTION SITE OF MOLONEY JRNL TITL 5 MURINE LEUKEMIA (PIM) 1, 2, AND 3 KINASE INHIBITOR IN JRNL TITL 6 CLINICAL TRIALS FOR HEMATOLOGICAL MALIGNANCIES. JRNL REF J.MED.CHEM. V. 58 8373 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 26505898 JRNL DOI 10.1021/ACS.JMEDCHEM.5B01275 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 25.44 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 30094 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.175 REMARK 3 R VALUE (WORKING SET) : 0.173 REMARK 3 FREE R VALUE : 0.202 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.070 REMARK 3 FREE R VALUE TEST SET COUNT : 1525 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 15 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.07 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.97 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2926 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1810 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2770 REMARK 3 BIN R VALUE (WORKING SET) : 0.1794 REMARK 3 BIN FREE R VALUE : 0.2088 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.33 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 156 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2224 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 32 REMARK 3 SOLVENT ATOMS : 248 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.76 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.66 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.32890 REMARK 3 B22 (A**2) : -0.32890 REMARK 3 B33 (A**2) : 0.65780 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.198 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.125 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.118 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.122 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.116 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.952 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.934 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2342 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3203 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 799 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 56 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 370 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2342 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 281 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2884 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.96 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.11 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.42 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5DWR COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-SEP-15. REMARK 100 THE DEPOSITION ID IS D_1000213909. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-MAY-09 REMARK 200 TEMPERATURE (KELVIN) : 160 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9765 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30274 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 42.590 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.100 REMARK 200 R MERGE (I) : 0.19400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 5.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.11 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.20 REMARK 200 R MERGE FOR SHELL (I) : 0.43600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.07 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.01 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALLANT: 0.6 TO 1.0 MM AMMONIUM REMARK 280 MONOPHOSPHATE (NH4)2HPO4, 200-350 MM SODIUM CHLORIDE, 0.1 M REMARK 280 CITRATE, PH 5.5, 1UL (10MG/ML) PROTEIN : 1UL CRYSTALLANT, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 65 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/6 REMARK 290 6555 X-Y,X,Z+5/6 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 54.08200 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 27.04100 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 40.56150 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 13.52050 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 67.60250 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -14 REMARK 465 ALA A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 HIS A -9 REMARK 465 HIS A -8 REMARK 465 HIS A -7 REMARK 465 LEU A -6 REMARK 465 GLU A -5 REMARK 465 VAL A -4 REMARK 465 LEU A -3 REMARK 465 PHE A -2 REMARK 465 GLN A -1 REMARK 465 GLY A 0 REMARK 465 PRO A 1 REMARK 465 LEU A 2 REMARK 465 LEU A 3 REMARK 465 SER A 4 REMARK 465 LYS A 5 REMARK 465 ILE A 6 REMARK 465 ASN A 7 REMARK 465 SER A 8 REMARK 465 LEU A 9 REMARK 465 ALA A 10 REMARK 465 HIS A 11 REMARK 465 LEU A 12 REMARK 465 ARG A 13 REMARK 465 ALA A 14 REMARK 465 ALA A 15 REMARK 465 PRO A 16 REMARK 465 CYS A 17 REMARK 465 ASN A 18 REMARK 465 ASP A 19 REMARK 465 LEU A 20 REMARK 465 HIS A 21 REMARK 465 ALA A 22 REMARK 465 THR A 23 REMARK 465 LYS A 24 REMARK 465 LEU A 25 REMARK 465 ALA A 26 REMARK 465 PRO A 27 REMARK 465 GLY A 28 REMARK 465 LYS A 29 REMARK 465 GLU A 30 REMARK 465 LYS A 31 REMARK 465 GLU A 32 REMARK 465 LEU A 307 REMARK 465 SER A 308 REMARK 465 PRO A 309 REMARK 465 GLY A 310 REMARK 465 PRO A 311 REMARK 465 SER A 312 REMARK 465 LYS A 313 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 80 CG CD1 CD2 REMARK 470 ASN A 82 CG OD1 ND2 REMARK 470 GLU A 243 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 82 39.29 -93.82 REMARK 500 ASP A 167 42.52 -146.75 REMARK 500 ASP A 186 84.97 64.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 5H7 A 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4N70 RELATED DB: PDB REMARK 900 4N70 CONTAINS THE SAME PROTEIN DBREF 5DWR A 2 313 UNP P11309 PIM1_HUMAN 93 404 SEQADV 5DWR MET A -14 UNP P11309 EXPRESSION TAG SEQADV 5DWR ALA A -13 UNP P11309 EXPRESSION TAG SEQADV 5DWR HIS A -12 UNP P11309 EXPRESSION TAG SEQADV 5DWR HIS A -11 UNP P11309 EXPRESSION TAG SEQADV 5DWR HIS A -10 UNP P11309 EXPRESSION TAG SEQADV 5DWR HIS A -9 UNP P11309 EXPRESSION TAG SEQADV 5DWR HIS A -8 UNP P11309 EXPRESSION TAG SEQADV 5DWR HIS A -7 UNP P11309 EXPRESSION TAG SEQADV 5DWR LEU A -6 UNP P11309 EXPRESSION TAG SEQADV 5DWR GLU A -5 UNP P11309 EXPRESSION TAG SEQADV 5DWR VAL A -4 UNP P11309 EXPRESSION TAG SEQADV 5DWR LEU A -3 UNP P11309 EXPRESSION TAG SEQADV 5DWR PHE A -2 UNP P11309 EXPRESSION TAG SEQADV 5DWR GLN A -1 UNP P11309 EXPRESSION TAG SEQADV 5DWR GLY A 0 UNP P11309 EXPRESSION TAG SEQADV 5DWR PRO A 1 UNP P11309 EXPRESSION TAG SEQRES 1 A 328 MET ALA HIS HIS HIS HIS HIS HIS LEU GLU VAL LEU PHE SEQRES 2 A 328 GLN GLY PRO LEU LEU SER LYS ILE ASN SER LEU ALA HIS SEQRES 3 A 328 LEU ARG ALA ALA PRO CYS ASN ASP LEU HIS ALA THR LYS SEQRES 4 A 328 LEU ALA PRO GLY LYS GLU LYS GLU PRO LEU GLU SER GLN SEQRES 5 A 328 TYR GLN VAL GLY PRO LEU LEU GLY SER GLY GLY PHE GLY SEQRES 6 A 328 SER VAL TYR SER GLY ILE ARG VAL SER ASP ASN LEU PRO SEQRES 7 A 328 VAL ALA ILE LYS HIS VAL GLU LYS ASP ARG ILE SER ASP SEQRES 8 A 328 TRP GLY GLU LEU PRO ASN GLY THR ARG VAL PRO MET GLU SEQRES 9 A 328 VAL VAL LEU LEU LYS LYS VAL SER SER GLY PHE SER GLY SEQRES 10 A 328 VAL ILE ARG LEU LEU ASP TRP PHE GLU ARG PRO ASP SER SEQRES 11 A 328 PHE VAL LEU ILE LEU GLU ARG PRO GLU PRO VAL GLN ASP SEQRES 12 A 328 LEU PHE ASP PHE ILE THR GLU ARG GLY ALA LEU GLN GLU SEQRES 13 A 328 GLU LEU ALA ARG SER PHE PHE TRP GLN VAL LEU GLU ALA SEQRES 14 A 328 VAL ARG HIS CYS HIS ASN CYS GLY VAL LEU HIS ARG ASP SEQRES 15 A 328 ILE LYS ASP GLU ASN ILE LEU ILE ASP LEU ASN ARG GLY SEQRES 16 A 328 GLU LEU LYS LEU ILE ASP PHE GLY SER GLY ALA LEU LEU SEQRES 17 A 328 LYS ASP THR VAL TYR THR ASP PHE ASP GLY THR ARG VAL SEQRES 18 A 328 TYR SER PRO PRO GLU TRP ILE ARG TYR HIS ARG TYR HIS SEQRES 19 A 328 GLY ARG SER ALA ALA VAL TRP SER LEU GLY ILE LEU LEU SEQRES 20 A 328 TYR ASP MET VAL CYS GLY ASP ILE PRO PHE GLU HIS ASP SEQRES 21 A 328 GLU GLU ILE ILE ARG GLY GLN VAL PHE PHE ARG GLN ARG SEQRES 22 A 328 VAL SER SEP GLU CYS GLN HIS LEU ILE ARG TRP CYS LEU SEQRES 23 A 328 ALA LEU ARG PRO SER ASP ARG PRO THR PHE GLU GLU ILE SEQRES 24 A 328 GLN ASN HIS PRO TRP MET GLN ASP VAL LEU LEU PRO GLN SEQRES 25 A 328 GLU THR ALA GLU ILE HIS LEU HIS SER LEU SER PRO GLY SEQRES 26 A 328 PRO SER LYS MODRES 5DWR SEP A 261 SER MODIFIED RESIDUE HET SEP A 261 10 HET 5H7 A 401 55 HETNAM SEP PHOSPHOSERINE HETNAM 5H7 N-{4-[(1R,3S,5S)-3-AMINO-5-METHYLCYCLOHEXYL]PYRIDIN-3- HETNAM 2 5H7 YL}-6-(2,6-DIFLUOROPHENYL)-5-FLUOROPYRIDINE-2- HETNAM 3 5H7 CARBOXAMIDE HETSYN SEP PHOSPHONOSERINE FORMUL 1 SEP C3 H8 N O6 P FORMUL 2 5H7 C24 H23 F3 N4 O FORMUL 3 HOH *248(H2 O) HELIX 1 AA1 ASP A 72 ILE A 74 5 3 HELIX 2 AA2 MET A 88 VAL A 96 1 9 HELIX 3 AA3 LEU A 129 GLY A 137 1 9 HELIX 4 AA4 GLN A 140 CYS A 161 1 22 HELIX 5 AA5 LYS A 169 GLU A 171 5 3 HELIX 6 AA6 THR A 204 SER A 208 5 5 HELIX 7 AA7 PRO A 209 HIS A 216 1 8 HELIX 8 AA8 HIS A 219 GLY A 238 1 20 HELIX 9 AA9 HIS A 244 GLY A 251 1 8 HELIX 10 AB1 SER A 260 LEU A 271 1 12 HELIX 11 AB2 ARG A 274 ARG A 278 5 5 HELIX 12 AB3 THR A 280 ASN A 286 1 7 HELIX 13 AB4 HIS A 287 GLN A 291 5 5 HELIX 14 AB5 LEU A 295 LEU A 304 1 10 SHEET 1 AA1 5 TYR A 38 GLY A 47 0 SHEET 2 AA1 5 GLY A 50 ARG A 57 -1 O VAL A 52 N LEU A 44 SHEET 3 AA1 5 PRO A 63 GLU A 70 -1 O ILE A 66 N TYR A 53 SHEET 4 AA1 5 SER A 115 GLU A 121 -1 O LEU A 120 N ALA A 65 SHEET 5 AA1 5 LEU A 106 GLU A 111 -1 N ASP A 108 O ILE A 119 SHEET 1 AA2 2 TRP A 77 GLU A 79 0 SHEET 2 AA2 2 ARG A 85 PRO A 87 -1 O VAL A 86 N GLY A 78 SHEET 1 AA3 3 VAL A 126 ASP A 128 0 SHEET 2 AA3 3 ILE A 173 ASP A 176 -1 O ILE A 175 N GLN A 127 SHEET 3 AA3 3 GLU A 181 LEU A 184 -1 O GLU A 181 N ASP A 176 SHEET 1 AA4 2 VAL A 163 LEU A 164 0 SHEET 2 AA4 2 ALA A 191 LEU A 192 -1 O ALA A 191 N LEU A 164 LINK C SER A 260 N SEP A 261 1555 1555 1.36 LINK C SEP A 261 N GLU A 262 1555 1555 1.35 CISPEP 1 GLU A 124 PRO A 125 0 1.17 SITE 1 AC1 18 LEU A 44 GLY A 45 PHE A 49 ALA A 65 SITE 2 AC1 18 LYS A 67 ILE A 104 LEU A 120 GLU A 121 SITE 3 AC1 18 ARG A 122 PRO A 123 VAL A 126 ASP A 128 SITE 4 AC1 18 GLU A 171 LEU A 174 ILE A 185 ASP A 186 SITE 5 AC1 18 HOH A 597 HOH A 612 CRYST1 98.233 98.233 81.123 90.00 90.00 120.00 P 65 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010180 0.005877 0.000000 0.00000 SCALE2 0.000000 0.011755 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012327 0.00000